SCHEMBL24076307

SCHEMBL24076307

CCOC(=O)Cn1nc(C(C)C)c2cc(C(F)(F)F)ccc2c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 3/20 0.58
▸ GAA P10253 1/20 0.48
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ TRPM2 O94759 1/20 0.44
▸ GPR139 Q6DWJ6 2/20 0.41
▸ FPR2 P25090 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ PPARG P37231 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ KCNN4 O15554 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24076255 0.93 NLRP3 (0.51) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24076983 0.93 NLRP3 (0.51) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL30231169 0.93 NLRP3 (0.51) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL25747492 0.93 NLRP3 (0.51) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24077075 0.92 NLRP3 (0.50) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24076232 0.92 NLRP3 (0.50) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24076927 0.92 NLRP3 (0.50) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24076293 0.92 NLRP3 (0.49) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24076227 0.91 NLRP3 (0.49) NLRP3GAACYP2C9CYP2C19CYP1A2
SCHEMBL24077343 0.90 CYP2C19 (0.52) NLRP3GAACYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230202989-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 — — US disclosed
US-20230202989-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 — — US disclosed
US-20230202989-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 — — US disclosed
WO-2021239885-A1 COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202989-A1 COMPOUNDS NLRP3, NLRP1, IL1B NLRP3 1/4885GAA 4369/4885CYP2C9 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback